Company Filing History:
2 out of 47 
1 out of 4,770 
1 out of 2,405 
Years Active: 2008-2013
Title: Innovations of Hideaki Imamura
Introduction
Hideaki Imamura is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating diabetes and related disorders. With a total of 3 patents, Imamura's work reflects a commitment to advancing medical science.
Latest Patents
One of Imamura's latest patents is for an acetyl pyrrolidinyl indole derivative. This invention relates to compounds that are useful for the treatment and prevention of diabetes mellitus, its complications, or obesity. The compounds exhibit glucokinase-activating effects and are presented in a specific formula. Another significant patent involves spirochromanone derivatives as acetyl coenzyme A carboxylase (ACC) inhibitors. This invention is aimed at providing therapeutic agents for various ACC-related disorders.
Career Highlights
Throughout his career, Imamura has worked with prominent companies in the pharmaceutical industry, including MSD K.K. and Merck & Company, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Imamura has collaborated with notable colleagues such as Hideki Jona and Takeru Yamakawa. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Hideaki Imamura's contributions to pharmaceutical innovations demonstrate his dedication to improving health outcomes through scientific advancements. His patents reflect a focus on addressing critical health issues, particularly diabetes and its complications.